Year in review 2015: Extracorporeal membrane oxygenation

Lakshmi Raman, Heidi J. Dalton

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) is a modified form of cardiopulmonary bypass. Although early trials were plagued by severe bleeding and high rates of death, subsequent experience with neonates found good survival, and ECMO became an important tool in the care of critically ill infants with respiratory failure. Since the 1980s, expansion to other groups (children, patients with cardiac disease, etc) followed as experience was obtained. Today, there is a rapid growth of ECMO, especially in the adult population. To date, >73,000 patients receiving ECMO have been reported to the international Extracorporeal Life Support Organization registry. This rapid growth in the usage of ECMO has made it possible for it to be included in the management algorithm of certain disease processes, such as ARDS, cardiopulmonary arrest, and septic shock. Significant advances in technology have made it possible to support patients on ECMO for weeks or months with success. Reduction in sedative use and experience with “awake” patients has led to ambulatory and mobile ECMO. Changes in ventilator support while on ECMO, even to the point of extubation, are also occurring. This article will review briefly some of the literature related to criteria for severity of illness before ECMO and related to ECMO care and practice. Issues relating to the use of ECMO as a resuscitative tool in cardiac arrest as well as the controversial topic of volume and outcome will also be presented.

Original languageEnglish (US)
Pages (from-to)986-991
Number of pages6
JournalRespiratory Care
Volume61
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Extracorporeal Membrane Oxygenation
Heart Arrest
Mechanical Ventilators
Septic Shock
Growth
Cardiopulmonary Bypass
Hypnotics and Sedatives
Critical Illness
Respiratory Insufficiency
Registries
Heart Diseases

Keywords

  • Bleeding
  • Cardiac arrest
  • Extracorporeal membrane oxygenation (ECMO)
  • Pediatric ARDS
  • Regionalization
  • Thrombosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Year in review 2015 : Extracorporeal membrane oxygenation. / Raman, Lakshmi; Dalton, Heidi J.

In: Respiratory Care, Vol. 61, No. 7, 01.07.2016, p. 986-991.

Research output: Contribution to journalArticle

Raman, Lakshmi ; Dalton, Heidi J. / Year in review 2015 : Extracorporeal membrane oxygenation. In: Respiratory Care. 2016 ; Vol. 61, No. 7. pp. 986-991.
@article{df170808888141e99671e48eaf43f343,
title = "Year in review 2015: Extracorporeal membrane oxygenation",
abstract = "Extracorporeal membrane oxygenation (ECMO) is a modified form of cardiopulmonary bypass. Although early trials were plagued by severe bleeding and high rates of death, subsequent experience with neonates found good survival, and ECMO became an important tool in the care of critically ill infants with respiratory failure. Since the 1980s, expansion to other groups (children, patients with cardiac disease, etc) followed as experience was obtained. Today, there is a rapid growth of ECMO, especially in the adult population. To date, >73,000 patients receiving ECMO have been reported to the international Extracorporeal Life Support Organization registry. This rapid growth in the usage of ECMO has made it possible for it to be included in the management algorithm of certain disease processes, such as ARDS, cardiopulmonary arrest, and septic shock. Significant advances in technology have made it possible to support patients on ECMO for weeks or months with success. Reduction in sedative use and experience with “awake” patients has led to ambulatory and mobile ECMO. Changes in ventilator support while on ECMO, even to the point of extubation, are also occurring. This article will review briefly some of the literature related to criteria for severity of illness before ECMO and related to ECMO care and practice. Issues relating to the use of ECMO as a resuscitative tool in cardiac arrest as well as the controversial topic of volume and outcome will also be presented.",
keywords = "Bleeding, Cardiac arrest, Extracorporeal membrane oxygenation (ECMO), Pediatric ARDS, Regionalization, Thrombosis",
author = "Lakshmi Raman and Dalton, {Heidi J.}",
year = "2016",
month = "7",
day = "1",
doi = "10.4187/respcare.04985",
language = "English (US)",
volume = "61",
pages = "986--991",
journal = "Respiratory Care",
issn = "0020-1324",
publisher = "Daedalus Enterprises Inc.",
number = "7",

}

TY - JOUR

T1 - Year in review 2015

T2 - Extracorporeal membrane oxygenation

AU - Raman, Lakshmi

AU - Dalton, Heidi J.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Extracorporeal membrane oxygenation (ECMO) is a modified form of cardiopulmonary bypass. Although early trials were plagued by severe bleeding and high rates of death, subsequent experience with neonates found good survival, and ECMO became an important tool in the care of critically ill infants with respiratory failure. Since the 1980s, expansion to other groups (children, patients with cardiac disease, etc) followed as experience was obtained. Today, there is a rapid growth of ECMO, especially in the adult population. To date, >73,000 patients receiving ECMO have been reported to the international Extracorporeal Life Support Organization registry. This rapid growth in the usage of ECMO has made it possible for it to be included in the management algorithm of certain disease processes, such as ARDS, cardiopulmonary arrest, and septic shock. Significant advances in technology have made it possible to support patients on ECMO for weeks or months with success. Reduction in sedative use and experience with “awake” patients has led to ambulatory and mobile ECMO. Changes in ventilator support while on ECMO, even to the point of extubation, are also occurring. This article will review briefly some of the literature related to criteria for severity of illness before ECMO and related to ECMO care and practice. Issues relating to the use of ECMO as a resuscitative tool in cardiac arrest as well as the controversial topic of volume and outcome will also be presented.

AB - Extracorporeal membrane oxygenation (ECMO) is a modified form of cardiopulmonary bypass. Although early trials were plagued by severe bleeding and high rates of death, subsequent experience with neonates found good survival, and ECMO became an important tool in the care of critically ill infants with respiratory failure. Since the 1980s, expansion to other groups (children, patients with cardiac disease, etc) followed as experience was obtained. Today, there is a rapid growth of ECMO, especially in the adult population. To date, >73,000 patients receiving ECMO have been reported to the international Extracorporeal Life Support Organization registry. This rapid growth in the usage of ECMO has made it possible for it to be included in the management algorithm of certain disease processes, such as ARDS, cardiopulmonary arrest, and septic shock. Significant advances in technology have made it possible to support patients on ECMO for weeks or months with success. Reduction in sedative use and experience with “awake” patients has led to ambulatory and mobile ECMO. Changes in ventilator support while on ECMO, even to the point of extubation, are also occurring. This article will review briefly some of the literature related to criteria for severity of illness before ECMO and related to ECMO care and practice. Issues relating to the use of ECMO as a resuscitative tool in cardiac arrest as well as the controversial topic of volume and outcome will also be presented.

KW - Bleeding

KW - Cardiac arrest

KW - Extracorporeal membrane oxygenation (ECMO)

KW - Pediatric ARDS

KW - Regionalization

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84977119179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977119179&partnerID=8YFLogxK

U2 - 10.4187/respcare.04985

DO - 10.4187/respcare.04985

M3 - Article

C2 - 27381702

AN - SCOPUS:84977119179

VL - 61

SP - 986

EP - 991

JO - Respiratory Care

JF - Respiratory Care

SN - 0020-1324

IS - 7

ER -